Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123277) titled 'xploratory Study: Adebrelimab Plus Chemotherapy in Neoadjuvant Treatment of Resectable Gastric Cancer' on April 23.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Shandong Provincial Qianfoshan Hospital
Condition:
gastric cancer
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-05-01
Target Sample Size: Intervention group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=319064
Published by HT Digital Content Services with permission from Health Daily Digest....